Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
D000616:Aminoglutethimide / Q000627:therapeutic use; D000726:Androgen Antagonists / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000502:physiology; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011372:Progestins / Q000037:antagonists & inhibitors; D011388:Prolactin / Q000037:antagonists & inhibitors; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D004965:Estrogen Antagonists; D006727:Hormone Antagonists; D011372:Progestins; D000616:Aminoglutethimide; D007987:Gonadotropin-Releasing Hormone; D011388:Prolactin